Bhubaneswar: Human clinical trials of the India’s indigenously developed COVID-19 vaccine will commence in Bhubaneswar from tomorrow.
The human clinical trials of COVAXIN, a vaccine developed by Bharat Biotech in collaboration with ICMR, will begin at Preventive and Therapeutic Clinical Trial Unit (PTCTU) of the Institute of Medical Sciences and SUM (IMS & SUM) Hospital here on Wednesday.
The IMS & SUM is one of the 12 centres selected by the ICMR for conducting phase one and two of the process of the vaccine.
The PTCTU would focus on clinical trials involving preventive and therapeutic aspects such as vaccines, immunoglobulins, preventive practices, chemoprophylactic drugs, educational/behavioural interventions and interventional agents or drugs.